Beta Bionics, Inc., a leader in diabetes management solutions, announced it will release its first quarter financial results for 2025 on May 6, 2025, after market close. Management will hold a ...
Net sales of $17.6 million, up 36% compared to $12.9 million in the first quarter of 2024. Durable Medical Equipment (DME) channel net sales of $13.8 million, up 14% compared to $12.1 million in the ...
I cannot think of a better choice than Bionic P&O as our first distributor for Ekso Indego Personal within the important orthotics and prosthetics industry.” “True innovation that supports patients in ...
Beta Bionics (NASDAQ:BBNX) reported fourth-quarter and full-year 2025 results on its earnings call Tuesday, highlighting ...
Why Ekso Bionics’ Price Target Just Moved Ekso Bionics Holdings just saw its price target reset to US$6, a level that bullish analysts link to the Q3 update and a view that the company is executing ...
IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results